Arkolith/Insider Trading/REPH/Form 4

Lake Ryan David

Chief Financial OfficerRecro Pharma, Inc. (REPH) · full profile →Form 4 · filed Jan 4, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2022Tax withholding(F)979$1.74$2K339K
Dec 31, 2021Tax withholding(F)29K$1.71$49K340K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-000720) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML